Fig. 2 | Signal Transduction and Targeted Therapy

Fig. 2

From: From tuberculosis bedside to bench: UBE2B splicing as a potential biomarker and its regulatory mechanism

Fig. 2

The splicing of selected four events in the in-house cohort-2. a The splicing of selected four events in the in-house cohort-2. The left scatters and right violin plots showed the distribution of PSI values and data density, respectively. The middle boxplot showed the median, two hinges, two whiskers, and outlying points. b–g Pirate plots of the target three splicing events in subgroups divided by combined disease, other treatment, clinical symptom, image feature, TB-related laboratory detection and anti-TB treatment, respectively. Points represented the raw data. The vertical bar and bands showed the mean and 95% highest density interval, respectively. The bean exhibited the data density. PSI percent spliced in, TB tuberculosis, HC healthy control, S100A8 S100 Calcium Binding Protein A8, RI intron retention, RPS20 Ribosomal Protein S20, AP alternate promoter, KIF13B Kinesin Family Member 13B, SE skipping exon, UBE2B Ubiquitin Conjugating Enzyme E2 B

Back to article page